This course is designed for healthcare professionals including doctors, nurses, and pharmacists who are involved in paediatric care. It focuses on the integration of evidence-based complementary therapies with conventional medical approaches, emphasising the management of paediatric conditions such as epilepsy, neurodevelopmental and behavioural disorders, and Paediatric Acute-onset Neuropsychiatric Syndrome (PANS). Participants will explore the use of cannabinoid-based medicines alongside lifestyle, diet, and supplement strategies, gaining practical insights into the endocannabinoid system’s role in brain development and child health. The course aims to equip prescribers with up-to-date, evidence-based education to improve their confidence in managing these complex conditions.

Successful completion will be one of the requirements under the ANZCCP HREC AP paediatric approval pathway.